All lobbying filings

VENABLE LLP

VENABLE LLP filed a Q3 report for ALLIANCE FOR AGING RESEARCH on October 16, 2026, reporting $50,000 in lobbying income.

Lobbying for ALLIANCE FOR AGING RESEARCH · Patient advocacy organization

All filings by VENABLE LLP · Everything ALLIANCE FOR AGING RESEARCH has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Oct 16, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

District of Columbia

Official filing document

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Implementation of Medicare Part D changes contained in Inflation Reduction Act: annual cap and smoothing; Medicare Part B and Part D drug pricing; Medicare Part D patient protections; Medicare quality measures for and staffing of long-term care and skilled nursing facilities; Increasing Medication Access for Seniors Act; FY 2027 Labor-HHS-Appropriations bill; FY 2027 Ag-FDA Appropriations bill; Treatments for neuropsychiatric symptoms associated with Alzheimer's and related dementias.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.